BREAKTHROUGHS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sphere of biopharmaceuticals, featuring promising enhancements across several medical and industrial applications. With its structural similarity to naturally derived human serum albumin, OsrHSA presents a safer, far more trustworthy alternative for therapeutic u